| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/17/2023 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 600k | $7.08 | $4.2M | | 08/17/2023 |
| 05/02/2023 | Edgewise Therapeutics, Inc. | | Sale | Common Stock | 3.2k | $8.90 | $28.5k | | 05/01/2023 |
| 05/01/2023 | Edgewise Therapeutics, Inc. | | Exercise | Restricted Stock Units | 10.4k | $0.00 | $0 | | 05/01/2023 |
| 08/08/2022 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 550k | $10.39 | $5.7M | | 08/08/2022 |
| 05/01/2022 | Edgewise Therapeutics, Inc. | | Grant | Restricted Stock Units | 31.2k | $0.00 | $0 | | 05/01/2022 |
| 08/17/2021 | Edgewise Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 400k | $16.38 | $6.6M | | 08/17/2021 |
| 05/21/2020 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Stock Option (right to buy) | 24k | $0.63 | $15k | | 05/21/2020 |
| 06/19/2019 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Stock Option (right to buy) | 12k | $2.36 | $28.3k | | 06/19/2019 |
| 06/27/2018 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Stock Option (right to buy) | 12k | $6.46 | $77.5k | | 06/27/2018 |
| 06/28/2017 | Viridian Therapeutics, Inc.\DE | MGEN | Grant | Stock Option (right to buy) | 12k | $12.06 | $144.7k | | 06/28/2017 |
| 07/24/2013 | ARRAY BIOPHARMA INC | ARRY | Payment of Exercise | Common Stock | 10.3k | $6.07 | $62.7k | | 07/24/2013 |
| 10/04/2012 | ARRAY BIOPHARMA INC | ARRY | Grant | Common Stock | 22.7k | $0.00 | $0 | | 10/04/2012 |
| 03/30/2012 | ARRAY BIOPHARMA INC | ARRY | Grant | Stock Option (Right to Buy) | 90k | $3.40 | $306k | | 03/30/2012 |
| 11/12/2009 | ARRAY BIOPHARMA INC | ARRY | Exercise | Stock Option (Right to Buy) | 28.9k | $0.60 | $17.3k | | 11/12/2009 |